One of the greatest challenges that breast cancer researchers face is understanding how and why secondary tumours form and finding new ways to tackle them. Secondary tumours occur when cancer cells escape from the breast and travel to other sites in the body such as the lungs, liver, bones and brain. Although
In addition to finding new ways to prevent and treat breast cancer, it’s crucial that we can identify how best to support patients and help them deal with the impact of their diagnosis and the side effects of treatment.
At Breast Cancer Now, we’re incredibly proud of all of the progress our researchers make and can frequently be found enthusiastically discussing the latest discoveries in our blogs. While we love to share the successes of our scientists, we also think it’s essential to talk about just how we decide which research to fund.
Research published today opens up the possibility that around 20% of breast cancer patients could benefit from drugs that have so far only been used in patients with inherited BRCA mutations. In this blog, we look at the many pieces of research that have contributed to this discovery.